38 results
424B5
COCP
Cocrystal Pharma Inc
27 Aug 20
Prospectus supplement for primary offering
5:24pm
our intellectual property portfolio; and
attracting, hiring and retaining qualified personnel.
Because of the numerous risks and uncertainties
424B5
COCP
Cocrystal Pharma Inc
26 Aug 20
Prospectus supplement for primary offering
5:30pm
our intellectual property portfolio; and
attracting, hiring and retaining qualified personnel.
Because of the numerous risks and uncertainties
8-K
EX-1.1
uvmdxbt
2 Jul 20
Entry into a Material Definitive Agreement
9:30am
424B5
e88fsnwx1jevpytcjcl
1 Jul 20
Prospectus supplement for primary offering
4:49pm
8-K
EX-10.1
vqt0025d5a ao
13 Mar 20
Cocrystal Pharma Announces Closing of $6.8 Million Registered Direct Offering Priced At-the-Market
4:44pm
424B5
ewqi75jpfo
10 Mar 20
Prospectus supplement for primary offering
3:04pm
8-K
EX-10.1
4gpwc
4 Mar 20
Cocrystal Pharma Announces Closing of $11.0 Million Registered Direct Offering Priced At-the-Market
5:09pm
424B5
gj4lvg
28 Feb 20
Prospectus supplement for primary offering
1:27pm
424B5
73njisc
31 Jan 20
Prospectus supplement for primary offering
8:03am
8-K
EX-10.1
jpsm yjrook6fkbq
31 Jan 20
Entry into a Material Definitive Agreement
8:01am
424B5
143awojbug2b s2lmo
31 Jan 20
Prospectus supplement for primary offering
8:01am
424B5
oq83bhpp8gp658251
31 Oct 19
Prospectus supplement for primary offering
4:05pm
424B5
qg14c0hc
31 Oct 19
Prospectus supplement for primary offering
4:02pm
424B5
gn0p2fq09y
30 Oct 19
Prospectus supplement for primary offering
4:59pm
424B5
q9kwpkzbtph9 g9gle
20 Jul 18
Prospectus supplement for primary offering
4:46pm